Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form
- PMID: 722741
- DOI: 10.1021/jm00210a029
Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form
Abstract
Platinum complexes derived from three isomers of 1,2-diaminocyclohexane have been synthesized and their antitumor activities were evaluated against ascites Sarcoma-180. All the platinum complexes had high antitumor activity. Platinum complexes derived from cis-1,2-diaminocyclohexane were more effective than those derived from trans-l-and trans-d-1,2-diaminocyclohexane. Among the platinum complexes tested, oxalato(cis-1,2-diminocyclohexane)platinum had a remarkably high therapeutic index. Modification of the nonleaving group as well as that of the leaving group is important in order to find better antitumor platinum complexes.
Similar articles
-
Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers.Gan. 1980 Oct;71(5):637-43. Gan. 1980. PMID: 7227714
-
Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.J Med Chem. 1989 Jan;32(1):128-36. doi: 10.1021/jm00121a024. J Med Chem. 1989. PMID: 2909724
-
Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.Cancer Res. 1986 Dec;46(12 Pt 1):6250-4. Cancer Res. 1986. PMID: 3779645
-
Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.J Med Chem. 1994 Aug 19;37(17):2630-6. doi: 10.1021/jm00043a003. J Med Chem. 1994. PMID: 8064793
-
Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.Metallomics. 2011 Jul;3(7):650-5. doi: 10.1039/c1mt00012h. Epub 2011 Apr 26. Metallomics. 2011. PMID: 21519596 Review.
Cited by
-
Highly and Broad-Spectrum In Vitro Antitumor Active cis-Dichloridoplatinum(II) Complexes with 7-Azaindoles.PLoS One. 2015 Aug 26;10(8):e0136338. doi: 10.1371/journal.pone.0136338. eCollection 2015. PLoS One. 2015. PMID: 26309251 Free PMC article.
-
Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases.Molecules. 2022 Apr 11;27(8):2466. doi: 10.3390/molecules27082466. Molecules. 2022. PMID: 35458666 Free PMC article. Review.
-
Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).J Biol Inorg Chem. 2010 Aug;15(6):841-50. doi: 10.1007/s00775-010-0648-8. Epub 2010 Mar 24. J Biol Inorg Chem. 2010. PMID: 20333420
-
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11. Chem Rev. 2016. PMID: 26865551 Free PMC article. Review.
-
Organic cation transporters are determinants of oxaliplatin cytotoxicity.Cancer Res. 2006 Sep 1;66(17):8847-57. doi: 10.1158/0008-5472.CAN-06-0769. Cancer Res. 2006. PMID: 16951202 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources